<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=ITI-1549</id>
	<title>ITI-1549 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=ITI-1549"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=ITI-1549&amp;action=history"/>
	<updated>2026-04-27T20:33:49Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=ITI-1549&amp;diff=6428632&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=ITI-1549&amp;diff=6428632&amp;oldid=prev"/>
		<updated>2025-03-05T06:39:16Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|A synthetic opioid analgesic}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| verifiedfields = changed&lt;br /&gt;
| verifiedrevid = 477318123&lt;br /&gt;
| IUPAC_name = (3R,4R)-3-(Dimethylamino)-1-(2-phenylethyl)-4-(phenylthio)piperidine&lt;br /&gt;
| image = ITI-1549_structure.png&lt;br /&gt;
| image2 = &lt;br /&gt;
| width = 200&lt;br /&gt;
| alt = &lt;br /&gt;
| caption = Chemical structure of ITI-1549&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;ITI-1549&amp;#039;&amp;#039;&amp;#039; is a synthetic [[opioid]] analgesic that was developed for the treatment of moderate to severe pain. It is part of a class of drugs known as [[piperidine]] derivatives, which are characterized by their potent analgesic properties.&lt;br /&gt;
&lt;br /&gt;
==Chemical Structure==&lt;br /&gt;
[[File:ITI-1549_structure.png|Chemical structure of ITI-1549|thumb|right]]&lt;br /&gt;
ITI-1549 is chemically classified as a piperidine derivative. Its IUPAC name is (3R,4R)-3-(Dimethylamino)-1-(2-phenylethyl)-4-(phenylthio)piperidine. The structure features a piperidine ring, which is a six-membered ring containing five carbon atoms and one nitrogen atom. The presence of a phenylthio group and a dimethylamino group contributes to its pharmacological activity.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
ITI-1549 acts primarily as an agonist at the [[mu-opioid receptor]], which is responsible for its analgesic effects. Activation of this receptor leads to the inhibition of [[neurotransmitter]] release, resulting in decreased perception of pain. Like other opioids, ITI-1549 can produce side effects such as [[sedation]], [[respiratory depression]], and [[euphoria]].&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
ITI-1549 was developed for the management of moderate to severe pain, particularly in cases where other analgesics are ineffective. Its use is typically restricted to controlled clinical settings due to the potential for abuse and dependence associated with opioid medications.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of ITI-1549 include [[nausea]], [[vomiting]], [[constipation]], and [[drowsiness]]. More serious side effects can include [[respiratory depression]], which can be life-threatening, especially in overdose situations. Long-term use can lead to [[tolerance]] and [[physical dependence]].&lt;br /&gt;
&lt;br /&gt;
==Legal Status==&lt;br /&gt;
The legal status of ITI-1549 varies by country, but it is generally classified as a controlled substance due to its potential for abuse and addiction. In many jurisdictions, it is available only by prescription and is subject to strict regulatory controls.&lt;br /&gt;
&lt;br /&gt;
==Related pages==&lt;br /&gt;
* [[Opioid]]&lt;br /&gt;
* [[Analgesic]]&lt;br /&gt;
* [[Piperidine]]&lt;br /&gt;
* [[Mu-opioid receptor]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Opioids]]&lt;br /&gt;
[[Category:Analgesics]]&lt;br /&gt;
[[Category:Piperidines]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>